|hold||SELL: 0%||HOLD: 80%||BUY: 20%|
|% From 52WK High||-50.10% (12,023)|
|% From 52WK Low||4.60% (5,736)|
|Business||Mediclinic is an international private healthcare services group with operating divisions in Switzerland, Southern Africa (South Africa and Namibia) and the United Arab Emirates. Its core purpose is to enhance the quality of life of...Read More|
|Results||March 2019 Final estimated to be released on Thursday , 23 May 2019|
|AGM||Next AGM date: Wednesday, 24 July 2019|
|Market Cap||R 44,234,628,600|
|P/E Ratio||11.68||Dividend Yield||SUB REQUIRED|
|Offshore Earnings Component||Med-High|
|12/12/2018||MEDICLINIC INTERNATIONAL PLC - Tax treatment of ordinary share dividend for shareholders on the South African register|
|12/12/2018||MEDICLINIC INTERNATIONAL PLC - Mediclinic Middle East site visit|
|10/12/2018||MEDICLINIC INTERNATIONAL PLC - Notification of major interest in Mediclinic International plc shares|
|20/11/2018||MEDICLINIC INTERNATIONAL PLC - Notification of major interest in Mediclinic International plc shares|
|20/11/2018||MEDICLINIC INTERNATIONAL PLC - Director declaration|
|15/11/2018||MEDICLINIC INTERNATIONAL PLC - Directorate change|
|15/11/2018||MEDICLINIC INTERNATIONAL PLC - Mediclinic International plc - 2018/19 interim results and declaration of interim cash dividend|
|Mediclinic is a private healthcare group with three operating platforms in Southern Africa (South Africa and Namibia), Switzerland and the United Arab Emirates. Its core purpose is to enhance the quality of life of patients by providing cost-effective acute care specialised healthcare services.
During February 2016 the reverse takeover by the Company (previously named Al Noor Hospitals Group plc), with operations mainly in Abu Dhabi in the United Arab Emirates, of Mediclinic International Limited, a South African based international private healthcare group founded in 1983 and listed on the JSE stock exchange in South Africa since 1986, with operations in South Africa, Namibia, Switzerland and the United Arab Emirates (mainly in Dubai), was completed. The combination resulted in the enlarged Mediclinic group now boasting 73 hospitals and 34 clinics.
Today, Mediclinic Southern Africa operates 49 hospitals and 2 day clinics throughout South Africa and 3 hospitals in Namibia with more than 7 900 inpatient beds in total; Hirslanden operates 16 private acute care facilities and 3 clinics in Switzerland with more than 1 600 inpatient beds; and Mediclinic Middle East operates 5 hospitals and 38 clinics with more than 600 inpatient beds in the United Arab Emirates.
Mediclinic also holds a 29.9% interest in Spire Healthcare, a LSE listed and UK-based private healthcare group.
Mediclinic puts science at the heart of its care approach, focusing on providing the best possible facilities with international-standard technology, which is backed-up by sound medical expertise and the empathy of its nursing staff.
Mediclinic is associated with the following companies/institutions: